Company Filing History:
Years Active: 2017
Title: Indasi J Gopi Kumar: Innovator in Antiviral Compounds
Introduction
Indasi J Gopi Kumar is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of antiviral research, particularly in the development of compounds targeting the Hepatitis C virus.
Latest Patents
Indasi holds 1 patent for his work on Hepatitis C virus inhibitors. This patent focuses on antiviral compounds that inhibit the function of the NS5A protein encoded by the Hepatitis C virus (HCV). The disclosure includes combinations of compounds, compositions comprising these combinations, and methods for effectively inhibiting the NS5A protein's function.
Career Highlights
Indasi is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research in antiviral therapies. His work is crucial in the ongoing battle against viral infections, particularly those caused by Hepatitis C.
Collaborations
Indasi has collaborated with several esteemed colleagues, including Piyasena Hewawasam and Omar D Lopez. These partnerships enhance the research and development of innovative antiviral solutions.
Conclusion
Indasi J Gopi Kumar's contributions to antiviral research, particularly through his patent on Hepatitis C virus inhibitors, highlight his role as a significant innovator in the field. His work continues to pave the way for advancements in antiviral therapies.